Sai‐Yang Zhang

2.5k total citations · 2 hit papers
103 papers, 1.9k citations indexed

About

Sai‐Yang Zhang is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Sai‐Yang Zhang has authored 103 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 50 papers in Organic Chemistry and 21 papers in Oncology. Recurrent topics in Sai‐Yang Zhang's work include Synthesis and biological activity (41 papers), Synthesis and Biological Evaluation (22 papers) and Click Chemistry and Applications (18 papers). Sai‐Yang Zhang is often cited by papers focused on Synthesis and biological activity (41 papers), Synthesis and Biological Evaluation (22 papers) and Click Chemistry and Applications (18 papers). Sai‐Yang Zhang collaborates with scholars based in China, New Zealand and United States. Sai‐Yang Zhang's co-authors include Jian Song, Yanbing Zhang, Dong‐Jun Fu, Hong‐Min Liu, Xiaolin Zi, Xin-Yi Tian, Xiujuan Liu, Cheng‐Yun Jin, Christopher Blair and Shuo Yuan and has published in prestigious journals such as Nature Communications, Scientific Reports and Carbohydrate Polymers.

In The Last Decade

Sai‐Yang Zhang

97 papers receiving 1.9k citations

Hit Papers

Recent development of multi-target VEGFR-2 inhibitors for... 2023 2026 2024 2025 2023 2024 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
    2023 93 citations Xiujuan Liu, Haojie Zhang et al. Bioorganic Chemistry profile →
  2. Annual review of PROTAC degraders as anticancer agents in 2022
    2024 61 citations Xiao Wang, Jian Song et al. European Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sai‐Yang Zhang China 27 970 934 329 144 118 103 1.9k
Roberta Bortolozzi Italy 28 1.4k 1.4× 798 0.9× 258 0.8× 133 0.9× 171 1.4× 74 2.1k
Yoan Ferandin France 25 904 0.9× 954 1.0× 410 1.2× 185 1.3× 179 1.5× 34 2.0k
Nishant Jain India 26 1.4k 1.4× 880 0.9× 177 0.5× 60 0.4× 186 1.6× 86 2.2k
Xuewei Wu China 15 463 0.5× 693 0.7× 212 0.6× 57 0.4× 127 1.1× 28 1.3k
Zhuang Yang China 23 680 0.7× 680 0.7× 253 0.8× 51 0.4× 113 1.0× 61 1.3k
Weige Zhang China 24 1.1k 1.1× 554 0.6× 175 0.5× 86 0.6× 136 1.2× 104 1.8k
Dong‐Jin Hwang United States 25 392 0.4× 756 0.8× 188 0.6× 160 1.1× 104 0.9× 43 1.6k
Amaury Farce France 23 775 0.8× 935 1.0× 263 0.8× 46 0.3× 186 1.6× 71 1.9k
April L. Risinger United States 25 515 0.5× 1.1k 1.1× 491 1.5× 413 2.9× 244 2.1× 78 1.8k
Kim F. McClure United States 22 823 0.8× 1.1k 1.1× 179 0.5× 80 0.6× 76 0.6× 40 2.0k

Countries citing papers authored by Sai‐Yang Zhang

Since Specialization
Citations

This map shows the geographic impact of Sai‐Yang Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sai‐Yang Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sai‐Yang Zhang more than expected).

Fields of papers citing papers by Sai‐Yang Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sai‐Yang Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sai‐Yang Zhang. The network helps show where Sai‐Yang Zhang may publish in the future.

Co-authorship network of co-authors of Sai‐Yang Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Sai‐Yang Zhang. A scholar is included among the top collaborators of Sai‐Yang Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sai‐Yang Zhang. Sai‐Yang Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Sai‐Yang, Boyuan Liu, Volker Bromm, & Florian Kühnel. (2026). Primordial Black Holes as Seeds for Extremely Overmassive Active Galactic Nuclei Observed by JWST. The Astrophysical Journal Letters. 1000(1). L19–L19.
2.
Liu, Yunhe, Ziyue Wang, Yifei Du, et al.. (2025). Thienopyrimidine: A promising scaffold in the development of kinase inhibitors with anticancer activities. Bioorganic & Medicinal Chemistry. 121. 118109–118109. 4 indexed citations
3.
4.
Wu, Ji, Ziyue Wang, Bingbing Chen, et al.. (2025). ALK-based dual inhibitors: Focus on recent development for non-small cell lung cancer therapy. European Journal of Medicinal Chemistry. 291. 117646–117646. 4 indexed citations
5.
Liu, Bian, et al.. (2025). The pan-cancer analysis of LRG1 and its potential role in kidney renal clear cell carcinoma. RSC Medicinal Chemistry. 16(4). 1781–1796.
6.
7.
Li, Na, Yunhe Liu, Ji Yuan Wu, et al.. (2024). Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics. European Journal of Medicinal Chemistry. 276. 116694–116694. 6 indexed citations
8.
Wang, Xiao, Na Li, Yunhe Liu, et al.. (2024). Targeting focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders. European Journal of Medicinal Chemistry. 276. 116678–116678. 15 indexed citations
9.
Wu, Bowen, Wenjing Huang, Yunhe Liu, et al.. (2024). Design, synthesis and biological evaluation of 1,2,3-triazole benzothiazole derivatives as tubulin polymerization inhibitors with potent anti-esophageal cancer activities. European Journal of Medicinal Chemistry. 265. 116118–116118. 19 indexed citations
10.
Song, Jian, Shenghui Wang, Xiao Wang, et al.. (2024). N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations. Chinese Chemical Letters. 36(2). 109678–109678. 5 indexed citations
11.
Gong, Qijie, Jian Song, Yihui Song, et al.. (2024). New techniques and strategies in drug discovery (2020–2024 update). Chinese Chemical Letters. 36(3). 110456–110456. 4 indexed citations
12.
13.
Liu, Xiujuan, Haojie Zhang, Lei Cheng, et al.. (2023). Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy. Bioorganic Chemistry. 133. 106425–106425. 93 indexed citations breakdown →
14.
15.
Li, Hongli, Lulu Dong, Qianyu Li, et al.. (2023). A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle. Molecules. 28(3). 1141–1141. 11 indexed citations
16.
17.
Yuan, Shuo, Hui Liu, Shengnan Zhang, et al.. (2022). New drug approvals for 2021: Synthesis and clinical applications. European Journal of Medicinal Chemistry. 245. 114898–114898. 34 indexed citations
18.
19.
Ilie, Cosmin, et al.. (2021). Constraining dark matter properties with the first generation of stars. Physical review. D. 104(12). 18 indexed citations
20.
Wu, Bowen, Xinxin Cui, Ting Zhu, et al.. (2020). Design, Synthesis and Anticancer Activity Studies of Novel Trimethoxyphenyl-quinoline Derivatives. Chinese Journal of Organic Chemistry. 40(4). 978–978. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta Bortolozzi Breakdown of academic impact, for papers by Yoan Ferandin Breakdown of academic impact, for papers by Nishant Jain Breakdown of academic impact, for papers by Xuewei Wu Breakdown of academic impact, for papers by Zhuang Yang Breakdown of academic impact, for papers by Weige Zhang Breakdown of academic impact, for papers by Dong‐Jin Hwang Breakdown of academic impact, for papers by Amaury Farce Breakdown of academic impact, for papers by April L. Risinger Breakdown of academic impact, for papers by Kim F. McClure
Rankless by CCL
2026